Helping clients maximize potential, minimize risk is the mission of
RESEARCH TRIANGLE PARK, N.C., Oct. 8 /CNW/ -- Quintiles Transnational
Corp. today announced the appointment of Jay D. Norman to serve as President
of its expanding Quintiles Consulting business, which helps pharmaceutical,
biotech and medical device companies maximize potential and minimize risk from
early discovery through commercialization.
Quintiles is investing in the growth of its consulting business to help
meet the needs of its customers as they face increasingly complex regulatory,
development and market challenges. Building on its current practice areas and
the global reach and expertise of its parent company, Quintiles Consulting's
offerings will encompass strategic product development, regulatory compliance,
and pricing and reimbursement.
"As the world's largest CRO, Quintiles is uniquely positioned to provide
our consulting clients with competitive advantages and insight as they
navigate the development process and look to expand the financial and
therapeutic potential of their products," said John Ratliff, Quintiles
Transnational Chief Operating Officer. "With Jay's experience in developing
consultancies, and the industry and former FDA experts we already have on
staff, Quintiles is poised to expand its footprint in the consulting arena."
Norman brings 25 years of experience in the consulting industry and a
strong track record of growth, most recently with Diamond Management and
Technology Consultants, where he served as President and Chief Operating
Officer. Norman's accomplishments at Diamond earned him recognition by
Consulting Magazine, which named him a "Top 25 Consultant" in 2006. Norman's
diverse background also includes positions of increasing leadership
responsibility at top firms such as PricewaterhouseCoopers Consulting,
McKinsey and Company, Inc. and Accenture.
"Quintiles Consulting is already recognized for its outstanding client
service and insight in providing practical solutions to regulatory
challenges," Norman said. "With the strategic investment Quintiles is making
in consulting services and the reputation we have from our existing practices,
we are well-positioned to become the premier global provider of strategic
consulting to the life sciences industry."
Quintiles Consulting has consultants based across the U.S. and Europe to
serve its global clients.
About Quintiles Transnational
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With 19,000 employees
and offices in more than 50 countries, it is focused on providing customers
with solutions that are the gold standard of the industry. For more
information, please visit the company's Web site at www.qtrn.com.
For further information:
For further information: Rachael Tarleton Fones, Media Relations,
+1-919-998-2136, email@example.com, or Greg Connors, Investor
Relations, +1-919-998-2000, firstname.lastname@example.org, both of Quintiles
Transnational Corp. Web Site: http://www.qtrn.com